Prof. Dr. med. Georg Schett

Lehrstuhl für Innere Medizin III Einrichtungen, die zum Universitätsklinikum Erlangen gehören

Colchicine inhibits monosodium urate crystal-mediated inflammation by influencing F-actin formation (2025) Zhu L, Wang Y, Shan L, Xue Y, Schett G, Herrmann M, Liu L Journal article GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets (2025) Dand N, Stuart PE, Bowes J, Ellinghaus D, Nititham J, Saklatvala JR, Teder-Laving M, et al. Journal article Toward digitally supported self-assessment of patients with idiopathic inflammatory myopathies (2025) Seese F, Roscher P, Coppers B, Greenfield J, Grahammer M, Kuhn S, Gupta L, et al. Journal article Sensor-assessed grasping time as a biomarker of functional impairment in rheumatoid arthritis (2025) Coppers B, Heinrich S, Tascilar K, Phutane U, Kleyer A, Simon D, Bräunig J, et al. Journal article, Original article Early detection of rheumatoid arthritis through patient empowerment by tailored digital monitoring and education: a feasibility study (2025) Pfeuffer N, Hartmann F, Grahammer M, Simon D, Schuster L, Kuhn S, Krönke G, et al. Journal article Impact of intravenous CT contrast agents on internal calibration techniques to determine trabecular BMD of the lumbar spine (2025) Bartenschlager S, Cavallaro AJ, Pogarell T, Uder M, Chaudry O, Schett G, Engelke K Journal article Melanoma bone metastasis-induced osteocyte ferroptosis via the HIF1α-HMOX1 axis (2025) Jia Y, Li R, Li Y, Kachler K, Meng X, Gießl A, Qin Y, et al. Journal article The risk of femoral fracture is increased in patients with ischemic stroke and transient ischemic attack—a population-based observational secondary analysis of the Austrian stroke cohort (2025) Heidinger M, Lang C, Ferrari J, Krebs S, Sykora M, Kleyhons R, Resch H, et al. Journal article Entheseal tissue signature in response to IL-17A inhibition in psoriatic arthritis: results from the EBIO entheseal biopsy study (2025) Raimondo MG, Mohammadian H, Rauber S, Alivernini S, Fedorchenko V, Rigau AR, Angeli MR, et al. Journal article Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial (2025) McInnes IB, Coates LC, Mease PJ, Ogdie A, Kavanaugh A, Eder L, Schett G, et al. Journal article